Boštjan Matos

Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates

Ivana Jovčevska, Neja Zupanec, Žiga Urlep et al. · Oncotarget · 2017 · 77 citations · Full text

Medicine, Biochemistry, Oncology +17

Expression of LOC285758, a potential long non-coding biomarker, is methylation-dependent and correlates with glioma malignancy grade

Alenka Matjašič, Mara Popović, Boštjan Matos et al. · Radiology and Oncology · 2017 · 22 citations · Full text

Medicine, Molecular Biology, Oncology +17

Dynamic expression of 11 miRNAs in 83 consecutive primary and corresponding recurrent glioblastoma: correlation to treatment, time to recurrence, overall survival and MGMT methylation status

Boštjan Matos, Emanuela Boštjančič, Alenka Matjašič et al. · Radiology and Oncology · 2018 · 21 citations · Full text

Medicine, Cancer Biology, Oncology +17

Use of 3D visualisation of medical images for planning and intraoperative localisation of superficial brain tumours: our experience

Tilen Žele, Boštjan Matos, Jernej Knific et al. · British Journal of Neurosurgery · 2010 · 14 citations

Medicine, Neurosurgery, Surgery +17

Neurosurgical training programme in selected european countries – from young neurosurgeons point of view

Ibrahim Omerhodžić, Mehmet Tönge, Boštjan Matos et al. · Turkish Neurosurgery · 2011 · 12 citations · Full text

Medicine, Medical Education, Neurosurgery +6